PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TRML vs. SLNO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TRML and SLNO is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

TRML vs. SLNO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tourmaline Bio Inc. (TRML) and Soleno Therapeutics, Inc. (SLNO). The values are adjusted to include any dividend payments, if applicable.

0.00%20.00%40.00%60.00%80.00%100.00%AugustSeptemberOctoberNovemberDecember2025
22.37%
-0.17%
TRML
SLNO

Key characteristics

Sharpe Ratio

TRML:

-0.54

SLNO:

0.08

Sortino Ratio

TRML:

-0.35

SLNO:

0.56

Omega Ratio

TRML:

0.95

SLNO:

1.06

Calmar Ratio

TRML:

-0.50

SLNO:

0.05

Martin Ratio

TRML:

-0.80

SLNO:

0.30

Ulcer Index

TRML:

53.06%

SLNO:

14.65%

Daily Std Dev

TRML:

79.26%

SLNO:

57.49%

Max Drawdown

TRML:

-94.97%

SLNO:

-99.86%

Current Drawdown

TRML:

-78.23%

SLNO:

-92.86%

Fundamentals

Market Cap

TRML:

$461.57M

SLNO:

$2.02B

EPS

TRML:

-$2.49

SLNO:

-$2.85

Total Revenue (TTM)

TRML:

$0.00

SLNO:

$0.00

Gross Profit (TTM)

TRML:

-$20.00K

SLNO:

-$984.00K

EBITDA (TTM)

TRML:

-$63.91M

SLNO:

-$124.16M

Returns By Period

In the year-to-date period, TRML achieves a -11.24% return, which is significantly lower than SLNO's 4.29% return.


TRML

YTD

-11.24%

1M

-9.41%

6M

22.37%

1Y

-40.57%

5Y*

N/A

10Y*

N/A

SLNO

YTD

4.29%

1M

3.56%

6M

-0.17%

1Y

7.60%

5Y*

1.87%

10Y*

-9.04%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TRML vs. SLNO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TRML
The Risk-Adjusted Performance Rank of TRML is 2222
Overall Rank
The Sharpe Ratio Rank of TRML is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of TRML is 2323
Sortino Ratio Rank
The Omega Ratio Rank of TRML is 2222
Omega Ratio Rank
The Calmar Ratio Rank of TRML is 1616
Calmar Ratio Rank
The Martin Ratio Rank of TRML is 2929
Martin Ratio Rank

SLNO
The Risk-Adjusted Performance Rank of SLNO is 4848
Overall Rank
The Sharpe Ratio Rank of SLNO is 4949
Sharpe Ratio Rank
The Sortino Ratio Rank of SLNO is 4747
Sortino Ratio Rank
The Omega Ratio Rank of SLNO is 4545
Omega Ratio Rank
The Calmar Ratio Rank of SLNO is 4848
Calmar Ratio Rank
The Martin Ratio Rank of SLNO is 4949
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TRML vs. SLNO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Tourmaline Bio Inc. (TRML) and Soleno Therapeutics, Inc. (SLNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for TRML, currently valued at -0.54, compared to the broader market-2.000.002.004.00-0.540.08
The chart of Sortino ratio for TRML, currently valued at -0.35, compared to the broader market-4.00-2.000.002.004.00-0.350.56
The chart of Omega ratio for TRML, currently valued at 0.95, compared to the broader market0.501.001.502.000.951.06
The chart of Calmar ratio for TRML, currently valued at -0.50, compared to the broader market0.002.004.006.00-0.500.15
The chart of Martin ratio for TRML, currently valued at -0.80, compared to the broader market-10.000.0010.0020.00-0.800.30
TRML
SLNO

The current TRML Sharpe Ratio is -0.54, which is lower than the SLNO Sharpe Ratio of 0.08. The chart below compares the historical Sharpe Ratios of TRML and SLNO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
-0.54
0.08
TRML
SLNO

Dividends

TRML vs. SLNO - Dividend Comparison

Neither TRML nor SLNO has paid dividends to shareholders.


TTM20242023
TRML
Tourmaline Bio Inc.
0.00%0.00%57.75%
SLNO
Soleno Therapeutics, Inc.
0.00%0.00%0.00%

Drawdowns

TRML vs. SLNO - Drawdown Comparison

The maximum TRML drawdown since its inception was -94.97%, roughly equal to the maximum SLNO drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for TRML and SLNO. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-78.23%
-20.78%
TRML
SLNO

Volatility

TRML vs. SLNO - Volatility Comparison

The current volatility for Tourmaline Bio Inc. (TRML) is 17.06%, while Soleno Therapeutics, Inc. (SLNO) has a volatility of 18.33%. This indicates that TRML experiences smaller price fluctuations and is considered to be less risky than SLNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
17.06%
18.33%
TRML
SLNO

Financials

TRML vs. SLNO - Financials Comparison

This section allows you to compare key financial metrics between Tourmaline Bio Inc. and Soleno Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab